Hewmun Lau
InvestorPrincipal at Broadview Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Principal on the Biopharma team involved in day-to-day investment activities. Brings 15 years in life sciences with prior roles at Merrimack Pharmaceuticals and Navigant Consulting.
Contact· self-published, not guessed
Experience
- Broadview Ventures IncPrincipalcurrent2019 — presentGreater Boston
- Longview VenturesPrincipalcurrent2019 — presentBoston, Massachusetts, United States
- Mosanna TherapeuticsMember Board of Directorscurrent2025 — present
- Basking BiosciencesBoard Observercurrent2020 — presentResearch Triangle Park, North Carolina
- Antag TherapeuticsBoard Observer2020 — 2024Copenhagen, Denmark
- RenovacorBoard Observer2020 — 2021Philadelphia, Pennsylvania
- MerrimackDirector of Corporate Development2018 — 2019Cambridge, MA
- MerrimackAssociate Director, New Product Planning and Business Development2017 — 2018Cambridge, MA
- MerrimackSenior Manager, Commercial Analytics - ONIVYDE2015 — 2017Cambridge, MA
- NavigantSenior Consultant (Life Sciences Practice)2012 — 2015Greater Boston
- NavigantSummer Associate (Life Sciences Practice)2011Boston, MA
- RXi Pharmaceuticals CorpSummer Intern2010Worcester, MA
- McLean HospitalResearch Associate2007 — 2009
- Millennium PharmaceuticalsResearch Assistant2006 — 2007Cambridge, MA
Skills & more
InvestmentsStrategic PlanningCardiovascular DiseaseLifesciences11Genetics4Data Analysis6Business Strategy4Drug Discovery7Financial Modeling3Life Sciences2Clinical Trials3Laboratory2
+4 more
Management ConsultingBusiness DevelopmentBiotechnologyStrategyLanguages Bahasa Malaysia · Cantonese · Mandarin
From Hewmun's professional profile.
Colleagues at Broadview Ventures
Annabel Chen-Tournoux
Investor at Broadview Ventures
Anubodh Sunny Varshney
Venture Advisor at Broadview Ventures
Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Christopher de Souza
Director at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Milan
Chief Scientific Officer, Leducq Corp at Broadview Ventures
David Prim
Principal at Broadview Ventures
Frequently asked questions
- Who is Hewmun Lau?
- Principal on the Biopharma team involved in day-to-day investment activities. Brings 15 years in life sciences with prior roles at Merrimack Pharmaceuticals and Navigant Consulting.
- Where does Hewmun Lau work?
- Hewmun Lau is Principal at Broadview Ventures.
- What check size does Hewmun Lau write?
- Hewmun Lau typically writes checks of $100K – $5M.
- Where did Hewmun Lau go to school?
- Hewmun Lau studied at MIT Sloan School of Management (MBA); Brandeis University (Biochemistry, Biology and Economics); Harvard-MIT Division of Health Sciences and Technology (MS, Biomedical Enterprise).
Same school
Also attended MIT Sloan School of Management582
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 576 more
Also attended Brandeis University84
Santiago ReganDirector of Business Development at Redpoint VenturesNicholas AdamsManaging Partner at Differential VenturesJohn KeiltyVenture Partner at Third Rock VenturesKevin GillisPartner and Chief Operating Officer at Third Rock VenturesSeth LieblichInvestment Team at 8VCAlex MorganInvestor at Khosla Ventures
+ 78 more
Shared employers
Also worked at Antag Therapeutics9
Iqbal MuftiOperating Partner - Portfolio Business Development at SR One Capital ManagementLene GerlachVenture Partner at Hadean VenturesAndrew BartholomewFounder and Managing Partner at Fulcrum VentureBrian PaulPartner at Tenaya CapitalJørgen Søberg PetersenSenior Partner at Novo HoldingsHelen GaffneyPartner at Novo Holdings
+ 3 more
Also worked at Renovacor2
Also worked at Merrimack5
Ulrik B. NielsenGeneral Partner at Mission BiocapitalNana Kusi MinkahAccounting and Operations Associate at Mission BiocapitalMichael LeeManaging Director at Syngenta Group VenturesThomas NeedhamDirector, Head of the Biopharma Practice at Broadview VenturesRizal FauziCEO at Malaysia Debt Ventures Bhd.
Also worked at Navigant35
Kate WilschutzChief Financial Officer, Revolution Funds at RevolutionYukitaka KojimaCFA at E12 Venture Capital, LlcRobb HutchinsPartner, Portfolio Growth at Jump CapitalMaggie RodneyPartner at MassiveChristina HangSr. Research Analyst at Sands Capital VenturesSmita ChowdhriController, Public Equity at Sofinnova Ventures
+ 29 more